Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin G Sanda

Showing results (81-90 of 180) with videos related to

Pageof 18
Sort By:
Urology|June 25, 2010
Comparison of validated instruments measuring sexual function in menAdam W Levinson, Nicholas T Ward, Martin G Sanda, et al.
BMC Cancer|August 28, 2015
The transcription factor ERG increases expression of neurotransmitter receptors on prostate cancer cellsHaydn T Kissick, Seung T On, Laura K Dunn, et al.
The Prostate|March 9, 2010
Androgen ablation augments human HLA2.1-restricted T cell responses to PSA self-antigen in transgenic miceMohamed S Arredouani, Stephanie S Tseng-Rogenski, Brent K Hollenbeck, et al.
JAMA|April 3, 2002
alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancerMark A Rubin, Ming Zhou, Saravana M Dhanasekaran, et al.
Urology|August 4, 2009
Detection of TMPRSS2-ERG fusion gene expression in prostate cancer specimens by a novel assay using branched DNABin Lu, Botoul Maqsodi, Wen Yang, et al.
Journal of the National Cancer Institute|June 3, 2004
Humoral immune response to alpha-methylacyl-CoA racemase and prostate cancerArun Sreekumar, Bharathi Laxman, Daniel R Rhodes, et al.
The Journal of Clinical Investigation|August 7, 2002
Huntingtin-interacting protein 1 is overexpressed in prostate and colon cancer and is critical for cellular survivalDinesh S Rao, Teresa S Hyun, Priti D Kumar, et al.
Magnetic Resonance Imaging|April 23, 2013
Diagnosis of relevant prostate cancer using supplementary cores from magnetic resonance imaging-prompted areas following multiple failed biopsiesDaniel N Costa, B Nicolas Bloch, David F Yao, et al.
Journal of the National Cancer Institute|July 10, 2014
Recommended patient-reported core set of symptoms to measure in prostate cancer treatment trialsRonald C Chen, Peter Chang, Richard J Vetter, et al.
BJU International|September 19, 2012
Uncertainty and perception of danger among patients undergoing treatment for prostate cancerMeredith Wallace Kazer, Donald E Bailey, Jonathan Chipman, et al.
Pageof 18

Showing results (81-90 of 180) with videos related to

Sort By:
Pageof 18
Urology|June 25, 2010
Comparison of validated instruments measuring sexual function in menAdam W Levinson, Nicholas T Ward, Martin G Sanda, et al.
BMC Cancer|August 28, 2015
The transcription factor ERG increases expression of neurotransmitter receptors on prostate cancer cellsHaydn T Kissick, Seung T On, Laura K Dunn, et al.
The Prostate|March 9, 2010
Androgen ablation augments human HLA2.1-restricted T cell responses to PSA self-antigen in transgenic miceMohamed S Arredouani, Stephanie S Tseng-Rogenski, Brent K Hollenbeck, et al.
JAMA|April 3, 2002
alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancerMark A Rubin, Ming Zhou, Saravana M Dhanasekaran, et al.
Urology|August 4, 2009
Detection of TMPRSS2-ERG fusion gene expression in prostate cancer specimens by a novel assay using branched DNABin Lu, Botoul Maqsodi, Wen Yang, et al.
Journal of the National Cancer Institute|June 3, 2004
Humoral immune response to alpha-methylacyl-CoA racemase and prostate cancerArun Sreekumar, Bharathi Laxman, Daniel R Rhodes, et al.
The Journal of Clinical Investigation|August 7, 2002
Huntingtin-interacting protein 1 is overexpressed in prostate and colon cancer and is critical for cellular survivalDinesh S Rao, Teresa S Hyun, Priti D Kumar, et al.
Magnetic Resonance Imaging|April 23, 2013
Diagnosis of relevant prostate cancer using supplementary cores from magnetic resonance imaging-prompted areas following multiple failed biopsiesDaniel N Costa, B Nicolas Bloch, David F Yao, et al.
Journal of the National Cancer Institute|July 10, 2014
Recommended patient-reported core set of symptoms to measure in prostate cancer treatment trialsRonald C Chen, Peter Chang, Richard J Vetter, et al.
BJU International|September 19, 2012
Uncertainty and perception of danger among patients undergoing treatment for prostate cancerMeredith Wallace Kazer, Donald E Bailey, Jonathan Chipman, et al.
Pageof 18